Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7254.00 | 7457.00 | 0.9728 | 0.9788 | |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 5000.00 | 1243.75 | 6960.00 | 7457.00 | 0.9334 | 0.9473 |
| BT-20 | Linsitinib | 0.01 | uM | 7 | 5000.00 | 1243.75 | 7182.00 | 7457.00 | 0.9631 | 0.9711 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 5000.00 | 1243.75 | 4314.00 | 7457.00 | 0.5785 | 0.6182 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 5000.00 | 1243.75 | 7522.00 | 7457.00 | 1.0087 | 1.0067 |
| BT-20 | 17-AAG | 1 | uM | 7 | 5000.00 | 1243.75 | 2467.00 | 7457.00 | 0.3308 | 0.3035 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 5000.00 | 1243.75 | 7348.00 | 7457.00 | 0.9854 | 0.9886 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 5000.00 | 1243.75 | 3470.00 | 7457.00 | 0.4653 | 0.4875 |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7203.00 | 7457.00 | 0.9659 | 0.9734 | |
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 5000.00 | 1243.75 | 5914.00 | 7457.00 | 0.7931 | 0.8284 |
| BT-20 | 17-AAG | 0.01 | uM | 7 | 5000.00 | 1243.75 | 6591.00 | 7457.00 | 0.8839 | 0.9067 |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7504.00 | 7457.00 | 1.0063 | 1.0049 | |
| BT-20 | Erlotinib | 10 | uM | 7 | 5000.00 | 1243.75 | 4532.00 | 7457.00 | 0.6078 | 0.6494 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 5000.00 | 1243.75 | 7555.00 | 7457.00 | 1.0131 | 1.0101 |
| BT-20 | Lapatinib | 10 | uM | 7 | 5000.00 | 1243.75 | 3463.00 | 7457.00 | 0.4644 | 0.4863 |
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 5000.00 | 1243.75 | 4977.00 | 7457.00 | 0.6674 | 0.7103 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 5000.00 | 1243.75 | 7788.00 | 7457.00 | 1.0444 | 1.0339 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 5000.00 | 1243.75 | 7569.00 | 7457.00 | 1.0150 | 1.0116 |
| BT-20 | Lapatinib | 1 | uM | 7 | 5000.00 | 1243.75 | 7142.00 | 7457.00 | 0.9578 | 0.9669 |
| BT-20 | 17-AAG | 0.1 | uM | 7 | 5000.00 | 1243.75 | 2469.00 | 7457.00 | 0.3311 | 0.3039 |
| BT-20 | Lapatinib | 0.01 | uM | 7 | 5000.00 | 1243.75 | 7662.00 | 7457.00 | 1.0275 | 1.0211 |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7975.00 | 7457.00 | 1.0695 | 1.0527 | |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 2.00 | 7457.00 | 0.0003 | -0.9171 | |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 2.00 | 7457.00 | 0.0003 | -0.9171 | |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 2.00 | 7457.00 | 0.0003 | -0.9171 |